Chamber and committees

The Scottish Government has been working in partnership with the Association of Directors of Education, COSLA and partners to establish the full delivery and financial requirements in support of the expansion of free school meals. Through this engagement, it has been confirmed that there is a requirement for capital and resource investment in order to support the expansion, including for catering and dining.

In addition to £53 million per year for universal provision in primary 1-3, the 2022-23 budget includes £42.2 million of revenue funding for the expansion of primary 4, 5 and special schools, and £30 million capital allocation for initial investment in school kitchens ahead of roll-out of free lunches to all primary school children during in the parliamentary term.

The Scottish Government will continue to work with partners in local authorities to plan for the expansion of free school lunch provision over the next academic year. This work will ensure the expansion can be delivered equitably across all schools, in all areas, whilst maintaining high quality lunch provision for pupils.

We announced on 14 February an agreement with the UK Government to deliver two Green Freeports in Scotland, working on an equal partnership basis. A package of reserved and devolved support will be available in the selected Green Freeports ensuring that Scotland can build globally competitive industrial clusters in the green industries of the future, deliver a just transition to net-zero, and create new high-quality, well-paid employment opportunities delivering Fair Work, including payment of the real living wage.

A competitive bidding process will be launched soon, with the winners to be announced later this year. As this will be a competitive, open and transparent process, I cannot prejudge this by commenting on possible locations.

Police Scotland have advised there are currently over 250 body worn cameras in use within North East Division. In addition, Police Scotland also equipped its Armed Policing officers ahead of COP26. In total 4.6 % of officers are currently equipped with Body worn Video (BWV). A consultation on a wider roll-out of body worn cameras closed in September 2021 and work is ongoing by Police Scotland to consider a national introduction.

The Scottish Government provided one off funding of £0.5m in 2021-22 to the Scottish Police Authority (SPA), to support the use of body-worn cameras for specialist officers for COP26.

For 2022-23, the total budget for policing is almost £1.4 billion, including an additional £40.5m increase in resource funding. The allocation of resources is a matter for the Scottish Police Authority and the Chief Constable.

Where it is clinically appropriate to do so, patients of all ages will be examined with a stethoscope to listen for breathing and heart sounds. They may also have ECG electrical recordings of their heart rate, blood tests and have access to other investigations such as echocardiograms, rhythm monitors and blood pressure recordings, should these be required.

The Heart Disease Action Plan (2021) outlines our commitment to exploring innovative models of care for the diagnosis of heart disease, including a focus on improving access to echocardiography in the most appropriate setting for local needs.

The contract was awarded under the Crown Commercial Service Management Consultancy Framework Three following a fair and open procurement exercise in line with Scottish Government guidance.

The Scottish Government has not carried out an assessment of any potential need for a public awareness campaign on the symptoms of heart valve disease.

However, the Heart Disease Action Plan, published in 2021, clearly sets out our strategic direction to minimise preventable heart disease and ensure that everyone with suspected heart disease in Scotland has timely and equitable access to diagnosis, treatment and care. This includes prioritizing the awareness of risk factors for cardiovascular disease.

Further, we have made commitments in the Women’s Health Plan to improve information and public awareness of heart disease symptoms and risks for women.

There is no conflict of interest between existing Scottish Government Civil Servants and the specialist consultancy services procured from KPMG in a fair and open procurement exercise. The Scottish Government has a clear contract award and management processes in place to prevent conflicts of interest and to support the delivery of fit for purpose outcomes. This includes clear requirements for separation of duties between finance and procurement decisions.

The Scottish Government is committed to ensuring that all school-aged children and young people in Scotland have access to a digital device by the end of this parliament in 2026.

Current guidance is being reviewed in collaboration with the sector, taking into account advice provided by the Covid-19 Advisory Sub-Group on Colleges and Universities. The Scottish Government’s 4 Harms approach ensures that the fullest range of impacts is taken into account in developing measures or guidance in all sectors, including for universities and colleges. Some students will already be receiving full time in-person teaching in line with our advice to prioritise students whose qualifications/progression are at risk. It is also for institutions to determine an appropriate balance between online and in-person teaching where that focuses on the reduction and management of risk and a cautious approach to keep people safe.

Kaftrio ® has been available for the treatment of cystic fibrosis in patients aged 12 years and older since 1 September 2020. This follows a pricing agreement with the manufacturer. There is provision in the access policy and pricing agreement for expanding access to Kaftrio ® as licence extensions are granted by the Medicines and Healthcare products Regulatory Agency (MHRA). The most recent extension in January 2022 allows for Kaftrio ® to be used in children aged 6 to 11 years.

This means that clinicians - working in cystic fibrosis treatment centres - can now prescribe Kaftrio ® for younger patients whom they consider will benefit from its use.